Related Experiment Video
Updated: Apr 16, 2026

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
Published on: July 18, 2017
"Peripherally inserted central catheters: our experience from a cancer research centre"
Deepak Sundriyal1, Nikhil Shirsi2, Ruchi Kapoor3
1Department of Medical oncology, Dharamshila Hospital & Research Centre, Vasundhara Enclave, New Delhi, 110096 India ; Department of Medical oncology, Dharamshila Hospital & Research Centre, 79 , Sector 12, Dwarka, New delhi, 110078 India.
This study analyzed complications of peripherally inserted central catheters (PICCs) in cancer patients. Results showed a higher rate of infective complications, though PICCs remain an acceptable drug delivery system.
Area of Science:
- Oncology
- Medical Devices
- Infectious Diseases
Background:
- Peripherally inserted central catheters (PICCs) are crucial for drug delivery in oncology.
- Understanding PICC-related complications is vital for patient safety and treatment efficacy.
Purpose of the Study:
- To determine the incidence and types of complications associated with PICC use in cancer patients over a one-year period.
Main Methods:
- A retrospective analysis of 246 PICCs inserted between July 2012 and June 2013.
- Data collection involved procedure room records, medical records, radiology, and microbiology departments.
- 223 cases were included in the final analysis after data verification.
Main Results:
- A total of 223 PICCs were analyzed, with 14 cases (6.3%) requiring ultrasound (USG) guidance.
- Optimal duration of PICC use was achieved in 151 patients (67.7%).
- Infective complications occurred in 28 patients (12.5%), and mechanical complications in 44 patients (19.7%).
Conclusions:
- The study identified a relatively high rate of infective complications associated with PICC use.
- Despite complications, PICCs are considered an acceptable and valuable drug delivery system in oncology practice.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015